New study links mitochondrial issues to autism subtypes

NCT ID NCT02000284

Ongoing Knowledge-focused Sponsor: University of Arkansas Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

Researchers at Arkansas Children's Hospital are studying how mitochondria work in children with autism spectrum disorder. They aim to identify distinct patterns of mitochondrial dysfunction that may relate to developmental delays. The study involves up to 5 visits with blood draws and behavioral assessments, and is currently following already enrolled participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help identify specific patterns of mitochondrial dysfunction in autism, leading to better diagnosis and targeted therapies.
What could go wrong: This is an observational study, not a treatment trial. It is small and focused on a specific population, so findings may not apply broadly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autism autism spectrum disorder autism spectrum disorder 1 inborn mitochondrial metabolism disorder learning disability mitochondrial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AUTISM AUTISM SPECTRUM DISORDER DEVELOPMENTAL DELAY MITOCHONDRIAL DISEASE

Contacts and locations

Locations

The University of Tennessee Health Science Center

Memphis, Tennessee, 38163, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.